Hot Deals:
5 star business 495.00 (-1.00 %) a v thomas 11,770.00 (-0.25 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 575.00 (0.88 %) arohan 181.00 (0.56 %) assam carbon 243.00 (-2.80 %) associated pigments limited 42.00 (-4.55 %) atlas copco 5,500.00 (1.85 %) auckland 130.00 (-3.70 %) axles 150.00 (11.11 %) b9 bira 772.00 (0.26 %) balmer lawrie van leer 300.00 bharat hotels 162.00 (1.25 %) bikaji foods 390.00 (1.04 %) boat 850.00 (-3.41 %) c & s electric 470.00 (-4.08 %) capgemini 11,000.00 (-2.22 %) care health 136.00 (-2.86 %) carrier aircon 260.00 (1.96 %) cial 180.00 (-1.64 %) csfbl 265.00 (-3.64 %) csk 160.00 (3.23 %) dalmia bharat refractories 81.00 (-4.71 %) east india pharmaceutical 39.00 (-2.50 %) eaton fluid 303.00 (1.00 %) electronica plastic 4,100.00 (-4.65 %) elgi ultra 400.00 elofic 1,909.00 (0.47 %) epiroc 1,224.00 (-2.08 %) esl steel 31.00 (-3.13 %) fincare 74.00 (1.37 %) fincare business services 43.00 fino paytech 145.00 (3.57 %) frick india 3,806.00 (0.16 %) gkn drive 1,051.00 (0.10 %) godavari biorefineries 71.00 (1.43 %) hdbfsl 600.00 (-2.44 %) hdfc ergo 363.80 hdfc securities 11,700.00 (1.74 %) hella india 190.00 (4.97 %) hero fincorp 714.00 (-1.24 %) hicks 2,100.00 (-2.55 %) hira ferro 121.00 (-3.20 %) honeywell electrical 3,555.00 (-1.25 %) icex 5.01 (0.20 %) incred financial 100.00 india carbon 1,060.00 (-3.64 %) india exposition mart 146.00 (0.69 %) indian potash limited 1,405.00 (0.36 %) indofil industries 700.00 (-1.41 %) infinite computer 700.00 inkel 12.95 (-0.38 %) ixigo 105.00 (-4.55 %) jana sfbl 75.00 kial 107.00 (-2.73 %) kurlon enterprise 640.00 (-3.03 %) kurlon limited 426.00 (-3.18 %) lava 123.00 (1.65 %) manipal hfsl 72.50 (0.69 %) manjushree technopack 1,010.00 (-3.81 %) martin and harris 1,980.00 (-1.98 %) merino 2,900.00 (-4.92 %) minosha 280.00 (-3.45 %) mitsubishi heavy industries 355.00 (1.43 %) mkcl 415.00 (1.22 %) mobikwik 450.00 (-4.26 %) mohan meakin 1,212.00 (1.00 %) mohfl 11.90 (-1.65 %) msei 1.00 (-4.76 %) msil 56.00 (3.70 %) nayara energy 150.00 (6.38 %) ncdex 275.00 ncl buildtek 175.00 (-5.41 %) ncl holdings 47.50 (1.06 %) nse 3,050.00 (-1.61 %) orbis financial 68.00 (1.49 %) oswal minerals 64.00 (-1.54 %) otis 3,800.00 (-2.56 %) oyo rooms 99.00 (-1.00 %) panasonic appliances 306.00 (0.33 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharm easy 38.00 (-2.56 %) philips domestic 570.00 (3.64 %) philips india 1,100.00 (1.85 %) pnb metlife 70.00 proyuga adtech 25.00 ramaraju surgical 530.00 (0.57 %) reliance general insurance 340.00 resins plastics 414.00 (1.97 %) ring plus 370.00 (1.37 %) rrl 3,000.00 (3.45 %) sabmiller 350.00 (-2.78 %) satya micro 200.00 scottish assam 565.00 (-0.88 %) shriram life 251.00 (0.40 %) signify 1,050.00 (-6.75 %) smile microfin 56.00 (1.82 %) sri vishnu shankar 510.00 (-2.30 %) sterlite power 925.00 (2.78 %) studds 1,155.00 (0.43 %) t stanes 675.00 tata tech 5,250.00 (0.96 %) tmbl 530.00 (-1.85 %) trl krosaki 1,224.00 (-2.16 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %) xerox 243.00 (1.25 %)
×

healthcaps india Limited

100.00
+ 0.00 %
Scrip Name
HEALTHCAPS
ISIN No.
INE936K01016
PAN No.
AAACC5021C
Face Value
10
No. of Outstanding Shares
4,037,190
Market Capitalization
40.37 Crore

HEALTHCAPS INDIA LIMITED UNLISTED SHARE

ABOUT HEALTHCAPS INDIA LIMITED


HEALTHCAPS INDIA LIMITED was incorporated on 06 December 1982. It is classified as a Non-govt company and is registered at Registrar of Companies, Chandigarh. Healthcaps India Limited is a WHO-GMP Certified Company and is in the production of Empty Hard Gelatin Capsule Shells (I.P. / B.P.).


Healthcaps India Limited products are widely used in the encapsulation of drugs, vitamins, antibiotics, etc, whether in powder or in pellet form by major pharmaceutical companies in India and abroad. Healthcaps India Limited also manufactures BSE/TSE-free EHG Capsules using EDQM approved gelatin.


With the objective of creating an eco-friendly environment, with stringent quality control checks in place the company chose the open spaces in Fatehpur, Punjab, 60 km from Chandigarh for its manufacturing facility. And to facilitate easy interaction with clients, it has established offices in Chandigarh, New Delhi, and Mumbai.


The company's vision is to become a global leader in the manufacture of empty capsules, setting benchmarks in quality and regulatory systems, and creating new market spaces with a focus on innovation.


INCORPORATION DETAILS


CIN

U74899PB1982PLC050929

Registration Date

06.12.1982

Category/Sub-category of the Company

 Public Company

Limited by shares

Company having share capital

Address of the Registered office and contact details

Tehsil Balachaur, District -SBS Nagar

(Nawanshahr), Punjab – 144522

Telephone: 01881-273637

Fax Number :

Email: info@healthcapsindia.com

Name, Address and Contact Details of

Registrar and Transfer Agent, if any

M/s Beetal Financial & Computer Services Pvt Ltd

Beetal House, 3rd Floor,99 Madangir,

Behind Local Shopping Center,

Near Data Harsukhdas Mandir

New Delhi- 110062

Ph: 011-29961284

Fax: 011-29961284

 

PRINCIPAL BUSINESS ACTIVITES OF THE COMPANY

Name and Description of main products/services

% to total turnover of the Company

Manufacture and Sale of Empty Hard Gelatin and HPMC Capsules

100%

 

BOARD OF DIRECTORS

Mr. Chiranjiv Singh (Managing Director)

Mrs. Hariti Singh (Whole Time Director)

Mr. I. S. Bindra (Director)

Mr. Gurucharan Singh (Independent Director)

Mr. ArunBhakoo (Independent Director)


PARTICULARS OF SUBSIDIARY AND ASSOCIATE COMPANIES

HEALTHCAPS INDIA LIMITED does not have any subsidiary or associate company.

 

HEALTHCAPS INDIA LIMITED SHARES DETAILS


Total Available Shares:

40,37,190

Face Value:

Rs. 10 Per Equity Share

ISIN:

INE936K01016

PAN No. :

AAACC5021C

Lot Size:

100

Last Traded Price:

Rs. 100

Market Cap:

Rs. 40.37 Crore

 

SHAREHOLDING PATTERN

(As on 31-03-2020)

S. No.

Shareholder’s Name

Number of shares

% of total Shares of the company

1

Chiranjiv Singh (Promoter)

26,50,468

65.65%

2

Hariti Singh (Promoter)

4,62,462

11.46%

3

Public Shareholding

9,24,260

22.89%


Total

40,37,190

100%

 

INDUSTRY OUTLOOK

Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability have helped India to manufacture pharma products at a very low cost.


The Indian healthcare market may see a 3 fold jump in terms of value to reach                 US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.


Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the Covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.


After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

 

 

 

PROFIT & LOSS STATEMENT OF HEALTHCAPS INDIA LIMITED                         (In Rs. Lakhs)

 

PARTICULARS

2020

2019

2018

Revenue from Operations

10,814.52

10,217.36

8,278.14

EBITDA

1,868.31

2,101.49

950.15

EBITDA margins

17.22%

20.53%

11.45%

Finance Cost

431.04

340.51

222.11

Depreciation

357.13

328.43

277.41

Other Income

35.01

16.34

21.17

Exceptional Items

2.60

(12.26)

(0.41)

Profit Before Tax

1,117.74

1,436.63

1,056.70

Total Tax

291.89

428.11

394.46

Profit After Tax (PAT)

825.85

1,008.52

662.24

PAT margin

7.61%

9.85%

7.98%

EPS (Rs.)

20.46

24.98

16.40


BALANCE SHEET OF HEALTHCAPS INDIA LIMITED (In Rs. Lakhs)

PARTICULARS

31st March 2020

31st March 2019

ASSETS



NON CURRENT ASSETS



Tangible assets

7,578.53

6,764.13

Intangible assets

1.89

1.03

Long-term Loans & Advances

195.40

248.14

Other non-current assets

14.40

1.69

TOTAL NON CURRENT ASSETS

7,790.22

7,014.98

CURRENT ASSETS



Inventories

2,214.93

1,725.03

Trade receivables

4,121.15

3,954.81

Cash and cash equivalent

297.48

276.71

Short-term Loans & Advances

470.53

461.50

Other current assets

14.96

15.33

TOTAL CURRENT ASSETS

7,119.05

6,433.39

TOTAL ASSETS

14,909.27

13,448.37

EQUITY AND LIABILITIES



EQUITY



Equity Share Capital

403.72

403.72

Other Equity

6,290.86

5,493.67

TOTAL EQUITY

6,694.58

5,897.39

LIABILITIES



NON CURRENT LIABILITIES



Long term borrowings

1,745.63

1,736.48

Provisions

477.57

400.25

Tax liabilities

846.28

796.30

TOTAL NON CURRENT LIABILITIES

3,069.48

2,933.03

CURRENT LIABILITIES



Trade payables

1,191.08

1,109.76

Short-term Borrowings

2,106.94

1,905.39

Provisions

238.28

309.59

Other current liabilities

1,608.90

1,293.21

TOTAL CURRENT LIABILITIES

5,145.21

4,617.95

TOTAL LIABILITIES

8,214.69

7,550.99

TOTAL EQUITY AND LIABILITIES

14,909.27

13,448.37

 

DIVIDEND HISTORY

Particulars

2020

2019

2018

Dividend (final + interim) (In Rs.)

Nil

Nil

Nil

 

PERFORMANCE OF THE COMPANY

Revenue from Operations of the company in FY 2020 was Rs. 10,814.52 Lakhs, as against Rs. 10,217.36 Lakhs in FY 2019. Revenue from Operations of the company increased by Rs. 597.16 Lakhs, which is about 6% increase.


EBITDA of the company decreased by 11.10% from Rs. 2,101.49 Lakhs in FY 2019 to Rs. 1,868.31 Lakhs in FY 2020. EBITDA margins decreased from 20.53% in                 FY 2019 to 17.22% in FY 2020.


In FY 2019, the company incurred a profit of Rs. 1,008.52 Lakhs. In FY 2020 the company made a profit of Rs. 825.85 Lakhs, i.e. decrease of 18.11% 


The Current Ratio of the company as of 31st March 2020 was 1.38.


The debt to Equity ratio of the company as of 31st March 2020 was 0.57.


Book value per share of the company as of 31st March 2020 stood at Rs. 165.82.


















 


Powered by Froala Editor

Annual Reports

2019-20

Download

2018-19

Download

2016-17

Download

Corporate Actions

2020-21

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi